Gabriele Murineddu

1.4k total citations
66 papers, 1.1k citations indexed

About

Gabriele Murineddu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Gabriele Murineddu has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 30 papers in Cellular and Molecular Neuroscience and 25 papers in Pharmacology. Recurrent topics in Gabriele Murineddu's work include Pharmacological Receptor Mechanisms and Effects (22 papers), Cannabis and Cannabinoid Research (21 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). Gabriele Murineddu is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (22 papers), Cannabis and Cannabinoid Research (21 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). Gabriele Murineddu collaborates with scholars based in Italy, Spain and United States. Gabriele Murineddu's co-authors include Gérard A. Pinna, Giorgio Chelucci, Giovanni Loriga, Battistina Asproni, Stefania Ruiu, Paolo Lazzari, Amedeo Pau, Luca Pani, G. Grella and Mauro A.M. Carai and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Gabriele Murineddu

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriele Murineddu Italy 19 689 356 322 224 97 66 1.1k
Serena Scapecchi Italy 20 456 0.7× 750 2.1× 205 0.6× 195 0.9× 65 0.7× 82 1.3k
Virendra Kumar United States 16 465 0.7× 344 1.0× 269 0.8× 198 0.9× 32 0.3× 61 945
Giovanni Loriga Italy 16 603 0.9× 186 0.5× 178 0.6× 137 0.6× 63 0.6× 32 826
Demetris P. Papahatjis Greece 21 820 1.2× 705 2.0× 533 1.7× 294 1.3× 43 0.4× 40 1.5k
Ivan O. Edafiogho United States 21 757 1.1× 267 0.8× 92 0.3× 112 0.5× 60 0.6× 54 1.3k
Michael A. Eissenstat United States 16 387 0.6× 290 0.8× 511 1.6× 367 1.6× 42 0.4× 32 1.0k
Cenzo Congiu Italy 25 1.2k 1.7× 411 1.2× 264 0.8× 57 0.3× 87 0.9× 79 1.7k
A. MARTINEZ‐GRAU Spain 20 858 1.2× 325 0.9× 292 0.9× 135 0.6× 29 0.3× 44 1.1k
Jacques Joubert South Africa 20 611 0.9× 368 1.0× 292 0.9× 78 0.3× 47 0.5× 63 1.1k
Douglas C. Beshore United States 16 451 0.7× 391 1.1× 114 0.4× 90 0.4× 52 0.5× 29 750

Countries citing papers authored by Gabriele Murineddu

Since Specialization
Citations

This map shows the geographic impact of Gabriele Murineddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Murineddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Murineddu more than expected).

Fields of papers citing papers by Gabriele Murineddu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriele Murineddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Murineddu. The network helps show where Gabriele Murineddu may publish in the future.

Co-authorship network of co-authors of Gabriele Murineddu

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriele Murineddu. A scholar is included among the top collaborators of Gabriele Murineddu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriele Murineddu. Gabriele Murineddu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asproni, Battistina, Gérard A. Pinna, Paola Corona, et al.. (2025). Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview. International Journal of Molecular Sciences. 26(8). 3806–3806.
2.
Corona, Paola, Stefania Gessi, Roberta Ibba, et al.. (2025). Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity. International Journal of Molecular Sciences. 26(4). 1439–1439. 1 indexed citations
3.
Murineddu, Gabriele, Gérard A. Pinna, Sonia Vanina Forcales, et al.. (2023). RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines. International Journal of Molecular Sciences. 24(14). 11263–11263. 5 indexed citations
4.
Asproni, Battistina, Marco Catto, Giovanni Loriga, et al.. (2023). Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction. Bioorganic & Medicinal Chemistry. 84. 117256–117256. 7 indexed citations
5.
Corona, Paola, et al.. (2022). Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity. European Journal of Medicinal Chemistry. 238. 114440–114440. 17 indexed citations
6.
Piras, Sandra, Gabriele Murineddu, Giovanni Loriga, et al.. (2021). Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. Molecules. 26(18). 5448–5448. 3 indexed citations
7.
Asproni, Battistina, Gabriele Murineddu, Paola Corona, & Gérard A. Pinna. (2021). Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction. Molecules. 26(8). 2126–2126. 3 indexed citations
8.
Zeng, Tiansheng, et al.. (2020). Target identification of a novel unsymmetrical 1,3,4‐oxadiazole derivative with antiproliferative properties. Journal of Cellular Physiology. 236(5). 3789–3799. 7 indexed citations
9.
Piras, Sandra, Paola Corona, Roberta Ibba, et al.. (2019). Preliminary Anti-Coxsackie Activity of Novel 1-[4-(5,6-dimethyl(H)- 1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas. Medicinal Chemistry. 16(5). 677–688. 6 indexed citations
10.
Murineddu, Gabriele, Battistina Asproni, Paola Corona, et al.. (2019). Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands. Molecules. 24(9). 1656–1656. 4 indexed citations
11.
Deiana, Valeria, María Gómez‐Cañas, M. Ruth Pazos, et al.. (2016). Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties. European Journal of Medicinal Chemistry. 112. 66–80. 18 indexed citations
12.
Loriga, Giovanni, et al.. (2015). Novel diazabicycloalkane delta opioid agonists. Bioorganic & Medicinal Chemistry. 23(17). 5527–5538. 4 indexed citations
13.
Dore, Antonio, Paolo Lazzari, Stefania Ruiu, et al.. (2014). Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands. European Journal of Medicinal Chemistry. 85. 747–757. 10 indexed citations
14.
Murineddu, Gabriele, Battistina Asproni, Stefania Ruiu, et al.. (2012). Tricyclic Pyrazoles. Part 5. Novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 Ligands Using Molecular Hybridization Based on Scaffold Hopping. PubMed. 6(1). 1–14. 17 indexed citations
15.
Murineddu, Gabriele, et al.. (2010). An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors. Current Medicinal Chemistry. 17(11). 1067–1091. 7 indexed citations
16.
Murineddu, Gabriele, Stefania Ruiu, Giovanni Loriga, et al.. (2005). Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors. Bioorganic & Medicinal Chemistry. 13(9). 3309–3320. 42 indexed citations
17.
Ruiu, Stefania, Amedeo Pau, Mauro A.M. Carai, et al.. (2003). Tricyclic Pyrazoles. Part 1: Synthesis and Biological Evaluation of Novel 1,4-Dihydroindeno[1,2-c]pyrazol-based Ligands for CB1and CB2 Cannabinoid Receptors. Bioorganic & Medicinal Chemistry. 11(2). 251–263. 49 indexed citations
18.
Grella, G., Marco Cabras, Gabriele Murineddu, A. Pau, & Gérard A. Pinna. (2003). Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles. European Journal of Pharmaceutical Sciences. 20(3). 267–272. 4 indexed citations
19.
Chelucci, Giorgio, Giovanni Loriga, Gabriele Murineddu, & Gérard A. Pinna. (2003). Synthesis of Chiral C2-Symmetric 1,10-Phenanthrolines from Naturally Occurring Monoterpenes. Synthesis. 73–78. 18 indexed citations
20.
Pinna, Gérard A., Giorgio Cignarella, Stefania Ruiu, et al.. (2003). Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3′ allyl end and at the phenyl ring of the cinnamyl chain on μ-receptor affinity and opioid antinociception. Bioorganic & Medicinal Chemistry. 11(18). 4015–4026. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serena Scapecchi Breakdown of academic impact, for papers by Virendra Kumar Breakdown of academic impact, for papers by Giovanni Loriga Breakdown of academic impact, for papers by Demetris P. Papahatjis Breakdown of academic impact, for papers by Ivan O. Edafiogho Breakdown of academic impact, for papers by Michael A. Eissenstat Breakdown of academic impact, for papers by Cenzo Congiu Breakdown of academic impact, for papers by A. MARTINEZ‐GRAU Breakdown of academic impact, for papers by Jacques Joubert Breakdown of academic impact, for papers by Douglas C. Beshore
Rankless by CCL
2026